LMH Strategic Solutions

LMH Strategic Solutions filed a Q2 report for Incyte Corporation on July 5, 2026, reporting $50,000 in lobbying income.

Lobbying for Incyte Corporation · Biopharmaceutical Company

As filed: LMH STRATEGIC SOLUTIONS for INCYTE CORPORATION.

All filings by LMH Strategic Solutions · Everything Incyte Corporation has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Oct 19, 2026.

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 5, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Delaware

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.

Pharmacy

Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.